A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy

Neuro-Oncology

Volumn 4, Issue 4, 2002, Pages 261-267

  Gilbert, Mark R ^a   Friedman, Henry S ^a   Kuttesch, John F ^a   Prados, Michael D ^a   Olson, Jeffrey J ^a   Reaman, Gregory H ^a   Zaknoen, Sara L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; TEMOZOLOMIDE;

ADULT; APNEA; ARTICLE; BLOOD TOXICITY; CANCER LOCALIZATION; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HUMAN; HYPERGLYCEMIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; SURVIVAL RATE; URINARY TRACT INFECTION;

EID: 0036788961     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/15228517-4-4-261     Document Type: Article

References (29)

1. Azizi, S.A., and Miyamoto, C. (1998) Principles of treatment of malignant gliomas in adults: An overview. J. Neurovirol. 4, 204-216.
2. Brada, M., Judson, I., Beale, P., Moore, S., Reidenberg, R, Statkevich, P., Dugan, M., Batra, V., and Cutler, D. (1999) Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies. Br. J. Cancer 81, 1022-1030.
3. Burger, P.C., Vogel, F.S., Green, S.B., and Strike, T.A. (1985) Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications. Cancer 56, 1106-1111.
4. Dazzi, C., Cariello, A., Giannini, M., Del Duca, M., Giovanis, R, Fiorentini, G., Leoni, M., Rosti, G., Turci, D., Tienghi, A., Vertogen, B., Zumaglini, F, De Giorgi, U., and Marangolo, M. (2000) A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: A phase II pilot study. Anticancer Res. 20, 515-518.
5. Dhodapkar, M., Rubin, J., Reid, J.M., Burch, P.A., Pitot, H.C., Buckner, J.C., Ames, M.M., and Suman, V.J. (1997) Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer Clin. Cancer Res. 3, 1093-1100.
6. Dropcho, E.J., Rosenfeld, S.S., Morawetz, R.B., Vitek, J., Brothers, M., Gonum, T., Bell, S., Gillespie, G.Y., Glantz, M., and Mahaley, M.S., Jr. (1992) Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium. J. Clin. Oncol. 10, 452-458.
7. Duffner, RK., Horowitz, M.E., Krischer, J.P., Friedman, H.S., Burger, P.C., Cohen, M.E., Sanford, R.A., Mulhern, R.K., James, H.E., Freeman, C.R., Seidel, F.G., and Kun, L.E. (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N. Engl. J. Med. 328, 1725-1731.
8. Fine, H.A., Dear, K.B., Loeffler, J.S., Black, P.M., and Canellos, G.P. (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71, 2585-2597.
9. 6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J. Clin. Oncol. 16, 3851-3857.
10. Friedman, H.S., Kerby, T., and Calvert, H. (2000) Temozolomide and treatment of malignant glioma. Clin. Cancer Res. 6, 2585-2597.
11. Gilbert, M., O'Neill, A., Grossman, S., Grunnet, M., Mehta, M., Jubelirer, S., and Hellman, R. (2000) A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: An Eastern Cooperative Oncology Group study (E2393). J. Neurooncol. 47, 145-152.
12. Greenlee, R.T., Hill-Harmon, M.B., Murray, T, and Thun, M. (2001) Cancer statistics, 2001. CA. Cancer J. Clin. 51, 15-36.
13. Jeremic, B., Shibamoto, Y., Grujicic, D., Milicic, B., Stojanovic, M., Nikolic, N., Dagovic, A., and Aleksandrovic, J. (1999) Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: A phase II study. Radiother. Oncol. 51, 27-33.
14. Kirby, S., Macdonald, D., Fisher, B., Gaspar, L., and Cairncross, G. (1996) Pre-radiation chemotherapy for malignant glioma in adults. Can. J. Neurol. Sci. 23, 123-127.
15. Lesser, G.J., and Grossman, S.A. (1993) The chemotherapy of adult primary brain tumors. Cancer Treat Rev. 19, 261-281.
16. Levin, VA., Silver, R, Hannigan, J., Wara, W.M., Gutin, PH., Davis, R.L., and Wilson, C.B. (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J. Radiat. Oncol. Biol. Phys. 18, 321-324.
17. Levin, V.A., Leibel, S.A., and Gutin, P.H. (1997) Neoplasms of the central nervous system. In: DeVita, VT, Jr., Hellman, S., and Rosenberg, S.A. (Eds.), Cancer: Principles and Practice of Oncology. Fifth edition. Philadelphia: Lippincott-Raven. pp. 2022-2082.
18. Macdonald, D.R., Cascino, T.L., Schold, S.C., Jr, and Cairncross, J.G. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J. Clin. Oncol. 8, 1277-1280.
19. Marzolini, C., Decosterd, L.A., Shen, F., Gander, M., Leyvraz, S., Bauer, J., Buclin, T., Biollaz, J., and Lejeune, F. (1998) Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: Comparison of oral, intravenous, and hepatic intra-arterial administration. Cancer Chemother. Pharmacol. 42, 433-440.
20. Newlands, E.S., Blackledge, G.R., Slack, J.A., Rustin, G.J., Smith, D.B., Stuart, N.S., Quarterman, C.P., Hoffman, R., Stevens, M.F, Brampton, M.H., and Gibson, A.C. (1992) Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J. Cancer 65, 287-291.
21. Newlands, E.S., O'Reilly, S.M., Glaser, M.G., Bower, M., Evans, H., Brock, C., Brampton, M.H., Colquhoun, I., Lewis, P., Rice-Edwards, J.M., Illingworth, R.D., and Richards, PG. (1996) The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur. J. Cancer 32A, 2236-2241.
22. O'Reilly, S.M., Newlands, E.S., Glaser, M.G., Brampton, M., Rice-Edwards, J.M., Illingworth, R.D., Richards, PG., Kennard, C., Colquhoun, I.R., Lewis, P., and Stevens, M.F.G. (1993) Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur. J. Cancer 29A, 940-942.
23. Patel, M., McCully, C., Godwin, K., and Balis, F. (1995) Plasma and cerebrospinal fluid pharmacokinetics of temozolomide. Proc Am. Soc Clin. Oncol. 14, 461. (Abstract)
24. Recht, L., Fram, R.J., Strauss, G., Fitzgerald, T.J., Liepman, M., Lew, R., Kadish, S., Sherman, D., Wilson, J., Greenberger, J., Egan, P., and Silver, D. (1990) Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU: A phase II trial. Am. J. Clin. Oncol. 13, 125-131.
25. Reid, J.M., Stevens, D.C., Rubin, J., and Ames, M.M. (1997) Pharmacokinetics of 3-methyl-(triazen-1-yl) imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer Clin. Cancer Res. 3, 2393-2398.
26. Solero, C.L., Monfardini, S., Brambilla, C., Vaghi, A., Valagussa, P., Morello, G., and Bonadonna, G. (1979) Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. Cancer Clin. Trials 2, 43-48.
27. Stupp, R., Dietrich, P.-Y., Ostermann Kraijevic, S., Pica, A., Maillard, I., Maeder, P., Meuli, R., Janzer, R., Pizzolato, G., Miralbell, R., Porchet, F, Regli, L., de Tribolet, N., Mirimanoff, R.O., and Leyvraz, S. (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J. Clin. Oncol. 20, 1375-1382.
28. Yung, W.K.A., Prados, M.D., Yaya-Tur, R., Rosenfeld, S.S., Brada, M., Friedman, H.S., Albright, R., Olson, J., Chang, S.M., O'Neill, A.M., Friedman, A.H., Bruner, J., Yue, N., Dugan, M., Zaknoen, S., and Levin, V.A. (1999) Multicenter phase II trial of temozolomide in patients with analplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J. Clin. Oncol. 17, 2762-2771.
29. Yung, W.K.A., Albright, R.E., Olson, J., Fredericks, R., Fink, K., Prados, M.D., Brada, M., Spence, A., Hohl, R.J., Shapiro, W., Glantz, M., Greenberg, H., Selker, R.G., Vick, N.A., Rampling, R., Friedman, H., Phillips, P., Bruner, J., Yue, N., Osoba, D., Zaknoen, S., and Levin, V.A. (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer 83, 588-593.